ÂÜÀòÂÒÂ×

Ms Whitaker (b. 1967) has more than 25 years of experience in the life sciences industry. She is currently Chairman of the Board for Aerami Therapeutics Holdings, Inc., having previously served as the Company's Chief Executive Officer and Director. She also currently serves as a member of the Board of Directors on Caladrius Biosciences Inc., Mallinckrodt Plc and Bryn Pharma, LLC.

Previously Ms Whittaker has held senior leadership positions at large pharmaceutical, biotech and speciality pharma companies including Chief Executive Officer at Novoclem Therapeutics, Inc. and Executive Vice President at Bausch Health, where she oversaw its Global Branded Pharmaceutical Business and the Western European Region. She was President and Chief Executive Officer of Synta Pharmaceuticals, President, North America Pharmaceuticals at Sanofi, where she oversaw all pharmaceutical and consumer healthcare operations for the region, and has also held several commercial leadership roles at GlaxoSmithKline.

Ms Whittaker was appointed to the Board as Non-Executive Director in April 2021.